Faculty Opinions recommendation of High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3162961.2851061 ◽

2010 ◽

Author(s):

David Hunter ◽

Grace Lo

Keyword(s):

Double Blind ◽

Double Blind Placebo ◽

Dose Comparison ◽

Parallel Group ◽

Download Full-text

High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study

Arthritis & Rheumatism ◽

10.1002/art.27327 ◽

2010 ◽

Vol 62 (4) ◽

pp. 1060-1068 ◽

Author(s):

Robert A. Terkeltaub ◽

Daniel E. Furst ◽

Katherine Bennett ◽

Karin A. Kook ◽

R. S. Crockett ◽

...

Keyword(s):

Double Blind ◽

Double Blind Placebo ◽

Dose Comparison ◽

Parallel Group ◽

Download Full-text

Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2012.04716.x ◽

2012 ◽

Vol 27 (3) ◽

pp. e376-e383 ◽

Author(s):

K.A. Papp ◽

R. Kaufmann ◽

D. Thaçi ◽

C. Hu ◽

D. Sutherland ◽

...

Keyword(s):

Phase Ii ◽

Plaque Psoriasis ◽

Comparison Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Severe Plaque Psoriasis ◽

Dose Comparison ◽

Download Full-text

IL-1 inhibitor anakinra is an effective alternative to standard treatments for reducing pain due to acute gout flare

Clinical Research in Practice The Journal of Team Hippocrates ◽

10.22237/crp/1593562920 ◽

2020 ◽

Vol 6 (2) ◽

Author(s):

Cheryl Craig

Keyword(s):

Standard Treatment ◽

Clinical Decision ◽

Effective Alternative ◽

Double Blind ◽

Double Blind Placebo ◽

Active Comparator ◽

A clinical decision report appraising Janssen CA, Voshaar MAHO, Vonkeman HE, et al. Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial. Rheumatology. 2019;58(8):1344-1352. https://doi.org/10.1093/rheumatology/key402 for a patient with an acute gouty attack refractory to standard treatment.

Download Full-text

A randomised, double-blind, placebo controlled, parallel group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue

Planta Medica ◽

10.1055/s-0029-1235006 ◽

2009 ◽

Vol 75 (09) ◽

Author(s):

EMG Olsson ◽

B von Schéele ◽

AG Panossian

Keyword(s):

Rhodiola Rosea ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Faculty Opinions recommendation of Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104054.560029 ◽

2008 ◽

Author(s):

Stephen Tyrer

Keyword(s):

Neuropathic Pain ◽

Evidence Based ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Parallel Group ◽

Download Full-text

Faculty Opinions recommendation of Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166121.627036 ◽

2009 ◽

Author(s):

Helen Kathryn Reddel ◽

Claude Farah

Keyword(s):

Clinical Trial ◽

Inhaled Corticosteroid ◽

Double Blind ◽

Double Blind Placebo ◽

Asthma Exacerbations ◽

Download Full-text

Faculty Opinions recommendation of Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952635.793458150 ◽

2012 ◽

Author(s):

Alex Thompson

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Dose Finding ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793478299 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Parallel Group Study ◽

Download Full-text

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text